Meet Us at DIA Europe 2025 – Booth I2
18 – 20 march – Basel, Switzerland Register Now DIA Europe 2025 will focus on sustainability, innovation and collaboration – three key pillars for shaping the future of healthcare. From the environmental impact of pharmaceuticals and of the drug development lifecycle to sustainable partnerships and sustainable healthcare systems, DIA Europe 2025 will be the prime opportunity to discuss how collaboration and […]
read more
Radiopharmaceutical Manufacturing: A High-Stakes Race Against Time
Med City News From the executive boardrooms of pharma companies to academic research centers, one fact is becoming unmistakably clear: making radiopharmaceuticals is an inherently complex, high-stakes endeavor, and the industry is racing to manage the risks of these perishable therapies before the clock runs out. Somewhere in a laboratory, tucked away in its vessel, […]
read more
Three Ways AI is Revolutionizing Clinical Development
Applied Clinical Trials Artificial intelligence (AI) is the biggest transformation in life sciences in the last 25 years—an advancement akin to mapping the human genome, with potential for a much higher rate of scientific breakthroughs over the next decade. But there’s still a lot to consider when applying AI to clinical development and product commercialization, […]
read more
Does research need to get data directly from people?
Norman Sabbah 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 𝐄𝐎𝐒𝐂𝟒𝐂𝐚𝐧𝐜𝐞𝐫 𝐜𝐚𝐧𝐜𝐞𝐫 𝐥𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞 𝐩𝐚𝐫𝐭𝐧𝐞𝐫𝐢𝐧𝐠 𝐦𝐞𝐞𝐭𝐢𝐧𝐠 On February 21, Norman Sabbah, COO at Telemedicine Technologies presented the latest advancements from WP5, focusing on D5.1, at the EOSC4Cancer Cancer Landscape Partnering Meeting. The session brought together 22 participants, fostering discussions on key developments in data-driven cancer research. His presentation, delivered as part […]
read more